Dementia due to multiple sclerosis (Q40240): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Demência devida à esclerose múltipla é uma doença neurodegenerativa devida aos efeitos cerebrais da esclerose múltipla, uma doença desmielinizante. O início dos sintomas é insidioso e não secundária ao comprometimento funcional atribuído à doença primária (i.e., a esclerose múltipla). Os comprometimentos cognitivos variam de acordo com a localização da desmielinização, mas tipicamente incluem déficits na velocidade de processamento, memória, atenção, e aspectos da funcionalidade executiva. | |||
| description / en | description / en | ||
Dementia due to multiple sclerosis is a neurodegenerative disease due to the cerebral effects of multiple sclerosis, a demyelinating disease. Onset of symptoms is insidious and not secondary to the functional impairment attributable to the primary disease (i.e., multiple sclerosis). Cognitive impairments vary according to the location of demyelination but typically include deficits in processing speed, memory, attention, and aspects of executive functioning. | |||
Revision as of 05:58, 13 August 2026
Dementia due to multiple sclerosis is a neurodegenerative disease due to the cerebral effects of multiple sclerosis, a demyelinating disease. Onset of symptoms is insidious and not secondary to the functional impairment attributable to the primary disease (i.e., multiple sclerosis). Cognitive impairments vary according to the location of demyelination but typically include deficits in processing speed, memory, attention, and aspects of executive functioning.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 6D85.4 |
||
| English | Dementia due to multiple sclerosis |
Dementia due to multiple sclerosis is a neurodegenerative disease due to the cerebral effects of multiple sclerosis, a demyelinating disease. Onset of symptoms is insidious and not secondary to the functional impairment attributable to the primary disease (i.e., multiple sclerosis). Cognitive impairments vary according to the location of demyelination but typically include deficits in processing speed, memory, attention, and aspects of executive functioning. |
